Cite
HARVARD Citation
Li, X. et al. (2022). Identifying patients with Crohn's disease at high risk of primary nonresponse to infliximab using a radiomic‐clinical model. International journal of intelligent systems. 37 (12), pp. 11853-11870. [Online].